Phillips-Medisize Showcases Connected Drug Delivery Devices at InnoPack
Hudson, WI – October 19, 2017 – Phillips-Medisize, LLC will present solutions for development and manufacture of drug delivery devices and primary pharmaceutical packaging, with a particular focus on connected health solutions where devices, connected services and drugs are completely integrated.
The continuum of Phillips-Medisize contract services featured include device strategy, product development, clinical and commercial manufacturing across specialty drug delivery devices, dosing systems, disposable insulin pens, inhalation devices, multi-component dosing units, spray applicators, as well as wearable drug delivery devices designed to improve patient engagement and drive better outcomes.
The use of electronic functional components is becoming a new prerequisite to facilitate the patients’ drug administration, ensure precise dosing quantity and timing, and predominantly raise drug delivery to the highest safety standards. The rise in complexity of a drug delivery device results in exponential growth of important factors which must be considered when following the individual steps of the entire value-creation chain. Customers, prospects, and other interested parties can learn about the values and benefits of choosing a trusted outsource partner and will be informed how Phillips-Medisize can help to make an idea of a complex drug delivery device a successful commercial product. Further, as part of Molex, Phillips-Medisize is now able to provide turn-key manufacturing solutions for customers developing electro-mechanical and connected health drug delivery systems.
For more information about Phillips-Medisize connected health solutions visit booth 42D32 at InnoPack.